Taylor SC. Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol. 2002;46(2 Suppl):S41-S62.
DOI:10.1067/mjd.2002.120790
Boo YC. Mechanistic basis and clinical evidence for the applications of nicotinamide (niacinamide) to control skin aging and pigmentation. Antioxidants (Basel). 2021;10(8):1315.
DOI:10.3390/antiox10081315
Lester JC, Taylor SC, Chren M-M. Under-representation of skin of colour in dermatology images: not just an educational issue. Br J Dermatol. 2019;180(6):1521-1522.
DOI:10.1111/bjd.17608
Adelekun A, Onyekaba G, Lipoff JB. Skin color in dermatology textbooks: an updated evaluation and analysis. J Am Acad Dermatol. 2021;84(1):194-196.
DOI:10.1016/j.jaad.2020.04.084
Culp MB, Lunsford NB. Melanoma among non-Hispanic Black Americans. Prev Chronic Dis. 2019;16:E79.
DOI:10.5888/pcd16.180640
Huang K, Fan J, Misra S. Acral lentiginous melanoma: incidence and survival in the United States, 2006-2015, an analysis of the SEER Registry. J Surg Res. 2020;251:329-339.
DOI:10.1016/j.jss.2020.02.010
Bradford PT. Skin cancer in skin of color. Dermatol Nurs. 2009;21(4):170-178; quiz 206. PMID:19691228
Agbai ON, Buster K, Sanchez M, et al. Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public. J Am Acad Dermatol. 2014;70(4):748-762.
DOI:10.1016/j.jaad.2013.11.038
Lyons AB, Trullas C, Kohli I, Hamzavi IH, Lim HW. Photoprotection beyond ultraviolet radiation: a review of tinted sunscreens. J Am Acad Dermatol. 2021;84(5):1393-1397.
DOI:10.1016/j.jaad.2020.04.079
Mancuso JB, Maruthi R, Wang SQ, Lim HW. Sunscreens: an update. Am J Clin Dermatol. 2017;18(5):643-650.
DOI:10.1007/s40257-017-0290-0
Alexis AF, Blackcloud P. Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances. J Clin Aesthet Dermatol. 2014;7(11):16-24.
Kaufman BP, Alexis AF. Psoriasis in skin of color: insights into the epidemiology, clinical presentation, genetics, quality-of-life impact, and treatment of psoriasis in non-white racial/ethnic groups. Am J Clin Dermatol. 2018;19(3):405-423.
DOI:10.1007/s40257-017-0332-7
Adawi W, Cornman H, Kambala A, Henry S, Kwatra SG. Diagnosing atopic dermatitis in skin of color. Dermatol Clin. 2023;41(3):417-429.
DOI:10.1016/j.det.2023.02.003
Ware OR, Dawson JE, Shinohara MM, Taylor SC. Racial limitations of Fitzpatrick skin type. Cutis. 2020;105(2):77-80.
Rodrigues M, Pandya AG. Melasma: clinical diagnosis and management options. Australas J Dermatol. 2015;56(3):151-163.
DOI:10.1111/ajd.12290
Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386(9988):74-84.
DOI:10.1016/S0140-6736(14)60763-7
Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol. 2002;47(5):789-791.
DOI:10.1067/mjd.2002.126250
Kohli I, Chaowattanapanit S, Mohammad TF, et al. Synergistic effects of long-wavelength ultraviolet A1 and visible light on pigmentation and erythema. Br J Dermatol. 2018;178(5):1173-1180.
DOI:10.1111/bjd.15940
Woolery-Lloyd HC, Kammer JN. Treatment of hyperpigmentation. Semin Cutan Med Surg. 2011;30(3):171-175.
DOI:10.1016/j.sder.2011.06.004
Alexis AF, Harper JC, Stein Gold LF, Tan JKL. Treating acne in patients with skin of color. Semin Cutan Med Surg. 2018;37(3S):S71-S73.
DOI:10.12788/j.sder.2018.027
Strober B, Thaçi D, Sofen H, et al. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 POETYK PSO-2 trial. J Am Acad Dermatol. 2023;88(1):40-51.
DOI:10.1016/j.jaad.2022.08.061
Aguh C, McMichael A. Central centrifugal cicatricial alopecia. JAMA Dermatol. 2020;156(9):1036.
DOI:10.1001/jamadermatol.2020.1859
McMichael AJ. Hair and scalp disorders in ethnic populations. Dermatol Clin. 2003;21(4):629-644.
DOI:10.1016/S0733-8635(03)00077-9
Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago. Plast Reconstr Surg. 2022;149(1):79e-94e.
DOI:10.1097/PRS.0000000000008667
Ward WH, Lambreton F, Goel N, Yu JQ, Farma JM. Clinical presentation and staging of melanoma. In: Ward WH, Farma JM, eds. Cutaneous Melanoma: Etiology and Therapy. Brisbane: Codon Publications; 2017. Chapter 6. DOI:10.15586/codon.cutaneousmelanoma.2017.ch6
Davis EC, Callender VD. A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol. 2010;3(4):24-38.
Adelekun A, Onyekaba G, Lipoff JB. Variation in skin color assessments across dark skin tones. J Am Acad Dermatol. 2022;86(2):459-460.
Grimes PE, Nashawati R. The role of diet and dietary supplementation in skin hyperpigmentation. Dermatol Clin. 2022;40(2):159-169.
DOI:10.1016/j.det.2021.10.004
Enechukwu NA, Behera B, Ding DD, et al. Dermoscopy of cutaneous neoplasms in skin of color—a systematic review by the International Dermoscopy Society « Imaging in Skin of Color » Task Force. Dermatol Pract Concept. 2023;13(4S1):e2023308S.
DOI:10.5826/dpc.1304S1a308S
Saida T, Koga H, Uhara H. Dermoscopy for acral melanocytic lesions: revision of the 3-step algorithm and refined definition of the regular and irregular fibrillar pattern. Dermatol Pract Concept. 2022;12(3):e2022123.
DOI:10.5826/dpc.1203a123
Chen V, Akhtar S, Zheng C, Kumaresan V, Nouri K. Assessment of changes in diversity in dermatology clinical trials between 2010-2015 and 2015-2020: a systematic review. JAMA Dermatol. 2022;158(3):288-292.
DOI:10.1001/jamadermatol.2021.5596
Alexis AF, Woolery-Lloyd H, Williams K, et al. Racial/ethnic variations in skin barrier: implications for skin care recommendations in skin of color. J Drugs Dermatol. 2021;20(9):932-938.
DOI:10.36849/JDD.6312
Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. Am J Clin Dermatol. 2018;19(4):489-503.
DOI:10.1007/s40257-017-0333-6
Lim HW, Collins SAB, Resneck JS Jr, et al. The burden of skin disease in the United States. J Am Acad Dermatol. 2017;76(5):958-972.e2.
DOI:10.1016/j.jaad.2016.12.043
Sivamani RK, Crane LA, Dellavalle RP. The benefits and risks of ultraviolet (UV) tanning and its alternatives: the role of prudent sun exposure. Dermatol Clin. 2009;27(2):149-154.
DOI:10.1016/j.det.2008.11.008
McKesey J, Tovar-Garza A, Pandya AG. Melasma treatment: an evidence-based review. Am J Clin Dermatol. 2020;21(2):173-225.
Rendon MI, Gaviria JI. Review of skin-lightening agents. Dermatol Surg. 2005;31(7 Pt 2):886-889.
DOI:10.1111/j.1524-4725.2005.31736
van Geel N, Speeckaert R, Taïeb A, et al. Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm. J Eur Acad Dermatol Venereol. 2023;37(11):2173-2184.
DOI:10.1111/jdv.19451
Skin of Color Society. Position Statement on Skin Cancer in Skin of Color. Washington DC: Skin of Color Society; 2022. skinofcolorsociety.org
World Health Organization. Skin conditions: key facts. Geneva: WHO; 2023. who.int